April 3, 2018
Morning Market Breakdown, April 3: After a Monday filled with losses, the major indexes continued to flounder going into Tuesday...
February 5, 2018
Opportunities abound when it comes to TSX pharmaceutical stocks, particularly those of the nano or micro cap variety, we're profiling...
December 13, 2017
Here are the five top stories that caught the attention of our investor audience in the pharmaceutical business during 2017.
December 11, 2017
Prometic Life Sciences announced PBI-4050, its orally-active drug candidate PBI-4050, received a Promising Innovative Medicine designation by the UK Medicines...
December 1, 2017
Prometic Life Sciences announced it closed an $80 million line of credit with Structured Alpha LP.
November 22, 2017
Prometic Life Sciences shared new interim data from six-month clinical data from its ongoing pivotal IVIG Phase 3 clinical trial...
October 26, 2017
Prometic Life Sciences announced it received approval for a phase 2 clinical trial by the Swedish Medical Products Agency.